I am/have/had
I am looking for
Advanced Filters
Found 196 clinical trials
Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma
This is an open-label, single-center, Phase II trial designed to estimate in terms of PFS the efficacy of cabozantinib, given as second- or third- line treatment in HCC patients that progress on or are intolerant to immune checkpoint inhibitors, including anti-PD-1 and anti-PD-L1 antibodies.
hepatocellular carcinoma
TACE
cabozantinib
renal function test
antiviral drugs
- 0 views
- 19 Feb, 2024
- 1 location
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma
The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.
monoclonal antibodies
hepatitis b surface antigen
liver cancer
monoclonal protein
pneumonia
- 0 views
- 19 Feb, 2024
- 1 location